Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4885)
All Articles published online
|
Oct 26, 2010 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | DeMarco VG, Whaley-Connell AT, Sowers JR, Habibi J, Dellsperger KC. Contribution of oxidative stress to pulmonary arterial hypertension. World J Cardiol 2010; 2(10): 316-324 [PMID: 21160609 DOI: 10.4330/wjc.v2.i10.316] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v2/i10/316.htm |
| Number | Citing Articles |
| 1 |
Juan Manuel Ramiro-Diaz, Carlos H. Nitta, Levi D. Maston, Simon Codianni, Wieslawa Giermakowska, Thomas C. Resta, Laura V. Gonzalez Bosc. NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice. American Journal of Physiology-Lung Cellular and Molecular Physiology 2013; 304(9): L613 doi: 10.1152/ajplung.00408.2012
|
| 2 |
Xian-Wei Li, Xiang-Ming Wang, Shu Li, Jie-Ren Yang. Effects of chrysin (5,7-dihydroxyflavone) on vascular remodeling in hypoxia-induced pulmonary hypertension in rats. Chinese Medicine 2015; 10(1): 4 doi: 10.1186/s13020-015-0032-2
|
| 3 |
Mario Boehm, Tatyana Novoyatleva, Baktybek Kojonazarov, Florian Veit, Norbert Weissmann, Hossein A. Ghofrani, Werner Seeger, Ralph T. Schermuly. Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis. American Journal of Respiratory Cell and Molecular Biology 2019; 60(3): 346 doi: 10.1165/rcmb.2018-0069OC
|
| 4 |
Patricia Siques, Eduardo Pena, Julio Brito, Samia El Alam. Oxidative Stress, Kinase Activation, and Inflammatory Pathways Involved in Effects on Smooth Muscle Cells During Pulmonary Artery Hypertension Under Hypobaric Hypoxia Exposure. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.690341
|
| 5 |
Michel R. Corboz, Tam L. Nguyen, Andy Stautberg, David Cipolla, Walter R. Perkins, Richard W. Chapman. Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2024; 37(5): 241 doi: 10.1089/jamp.2024.0016
|
| 6 |
Yu Ueda, Lynelle R. Johnson, Eric S. Ontiveros, Lance C. Visser, Catherine T. Gunther-Harrington, Joshua A. Stern. Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43318-z
|
| 7 |
Marianne Riou, Abrar Alfatni, Anne-Laure Charles, Emmanuel Andrès, Cristina Pistea, Anne Charloux, Bernard Geny. New Insights into the Implication of Mitochondrial Dysfunction in Tissue, Peripheral Blood Mononuclear Cells, and Platelets during Lung Diseases. Journal of Clinical Medicine 2020; 9(5): 1253 doi: 10.3390/jcm9051253
|
| 8 |
Paula Poyatos, Miquel Gratacós, Kay Samuel, Ramon Orriols, Olga Tura-Ceide. Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension. Antioxidants 2023; 12(5): 1006 doi: 10.3390/antiox12051006
|
| 9 |
Derek A. Kruse, Kristina L. Bailey. Geriatrics for Specialists. 2021; : 325 doi: 10.1007/978-3-030-76271-1_25
|
| 10 |
Cristina Campos-Carraro, Patrick Turck, Bruna Gazzi de Lima-Seolin, Rayane Brinck Teixeira, Alexsandra Zimmer, Alex Sander da Rosa Araujo, Adriane Belló-Klein. Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats. Canadian Journal of Physiology and Pharmacology 2023; 101(9): 447 doi: 10.1139/cjpp-2023-0028
|
| 11 |
Kunming Tian, Sayoko Ogura, Peter J. Little, Suo‐wen Xu, Tatsuya Sawamura. Targeting LOX‐1 in atherosclerosis and vasculopathy: current knowledge and future perspectives. Annals of the New York Academy of Sciences 2019; 1443(1): 34 doi: 10.1111/nyas.13984
|
| 12 |
Gerald J Maarman, Rainer Schulz, Karen Sliwa, Ralph Theo Schermuly, Sandrine Lecour. Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature. British Journal of Pharmacology 2017; 174(7): 497 doi: 10.1111/bph.13721
|
| 13 |
Himanshu Meghwani, Pankaj Prabhakar, Soheb A. Mohammed, Pamila Dua, Sandeep Seth, Milind P. Hote, Sanjay K. Banerjee, Sudheer Arava, Ruma Ray, Subir Kumar Maulik. Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats. Medicines 2018; 5(2): 34 doi: 10.3390/medicines5020034
|
| 14 |
R.C.P. Luna, Y. de Oliveira, J.V.C. Lisboa, T.R. Chaves, T.A.M. de Araújo, E.E. de Sousa, M. Miranda Neto, L. Pirola, V.A. Braga, J.L. de Brito Alves. Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension. Brazilian Journal of Medical and Biological Research 2018; 51(12) doi: 10.1590/1414-431x20187437
|
| 15 |
Anne Katrine Z. Johansen, Afshan Dean, Ian Morecroft, Katie Hood, Margaret Nilsen, Lynn Loughlin, Aikaterini Anagnostopoulou, Rhian M. Touyz, Kevin White, Margaret R. MacLean. The Serotonin Transporter Promotes a Pathological Estrogen Metabolic Pathway in Pulmonary Hypertension via Cytochrome P450 1B1. Pulmonary Circulation 2016; 6(1): 82 doi: 10.1086/685023
|
| 16 |
Chaoyi Qin, Yiheng Zan, Liang Xie, Hanmin Liu. Ataxia telangiectasia mutated: The potential negative regulator in platelet-derived growth factor-BB promoted proliferation of pulmonary arterial smooth muscle cells. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.942251
|
| 17 |
Dewei Peng, Aizan Wang, Wei Shi, Li Lin. Pentacyclic triterpenes, potential novel therapeutic approaches for cardiovascular diseases. Archives of Pharmacal Research 2024; 47(8-9): 709 doi: 10.1007/s12272-024-01510-4
|
| 18 |
Salil Sharma, Grégoire Ruffenach, Soban Umar, Negar Motayagheni, Srinivasa T. Reddy, Mansoureh Eghbali. Role of Oxidized Lipids in Pulmonary Arterial Hypertension. Pulmonary Circulation 2016; 6(3): 261 doi: 10.1086/687293
|
| 19 |
Joshua P. Fessel, Charles R. Flynn, Linda J. Robinson, Niki L. Penner, Santhi Gladson, Christie J. Kang, David H. Wasserman, Anna R. Hemnes, James D. West. Hyperoxia Synergizes with Mutant Bone Morphogenic Protein Receptor 2 to Cause Metabolic Stress, Oxidant Injury, and Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology 2013; 49(5): 778 doi: 10.1165/rcmb.2012-0463OC
|
| 20 |
Cristina Campos Carraro, Patrick Turck, Alan Bahr, Luiza Donatti, Giana Corssac, Denise Lacerda, Alex Sander da Rosa Araujo, Alexandre Luz de Castro, Letícia Koester, Adriane Belló-Klein. Effect of free and nanoemulsified β-caryophyllene on monocrotaline-induced pulmonary arterial hypertension. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2024; 1871(4): 119704 doi: 10.1016/j.bbamcr.2024.119704
|
| 21 |
V Fidan, H Alp, F Karaca, AD Ozcan, K Ozcan. Effect of Endoscopic Sinus Surgery on Plasma Asymmetric Dimethylarginine Levels in Patients with Extensive Nasal Polyposis. Journal of International Medical Research 2012; 40(2): 565 doi: 10.1177/147323001204000218
|
| 22 |
A. Zimmer, R. B. Teixeira, J. H. P. Bonetto, R. Siqueira, C. C. Carraro, L. M. Donatti, A. Hickmann, I. E. Litvin, A. E. G. Godoy, A. S. Araujo, R. Colombo, Adriane Belló-Klein. Effects of aerobic exercise training on metabolism of nitric oxide and endothelin-1 in lung parenchyma of rats with pulmonary arterial hypertension. Molecular and Cellular Biochemistry 2017; 429(1-2): 73 doi: 10.1007/s11010-016-2937-1
|
| 23 |
Ahmad Beik, Hamid Najafipour, Siyavash Joukar, Soodeh Rajabi, Maryam Iranpour, Zeinab Kordestani. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects. Clinical and Experimental Hypertension 2021; 43(3): 270 doi: 10.1080/10641963.2020.1860080
|
| 24 |
Jialing Wang, Hailong Li, Tian Xia, Jun Feng, Ru Zhou. Pulmonary Arterial Hypertension and Flavonoids. Chinese Journal of Physiology 2021; 64(3): 115 doi: 10.4103/cjp.cjp_25_21
|
| 25 |
Tetsuo Toyama, Tatiana V. Kudryashova, Asako Ichihara, Stefania Lenna, Agnieszka Looney, Yuanjun Shen, Lifeng Jiang, Leyla Teos, Theodore Avolio, Derek Lin, Ulas Kaplan, Grace Marden, Vrinda Dambal, Dmitry Goncharov, Horace Delisser, Robert Lafyatis, Francesca Seta, Elena A. Goncharova, Maria Trojanowska. GATA6 coordinates cross-talk between BMP10 and oxidative stress axis in pulmonary arterial hypertension. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33779-8
|
| 26 |
Norbert F. Voelkel, Harm J. Bogaard, Aysar Al Husseini, Laszlo Farkas, Jose Gomez-Arroyo, Ramesh Natarajan. Antioxidants for the Treatment of Patients with Severe Angioproliferative Pulmonary Hypertension?. Antioxidants & Redox Signaling 2013; 18(14): 1810 doi: 10.1089/ars.2012.4828
|
| 27 |
Ronald Zolty. Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension. Journal of Experimental Pharmacology 2021; : 817 doi: 10.2147/JEP.S236743
|
| 28 |
Victor H. Ruiz, David Encinas-Basurto, Neftali Ortega-Alarcon, Basanth Babu Eedara, Jeffrey R. Fineman, Stephen M. Black, Heidi M. Mansour. Inhalable Advanced Co-Spray Dried Microparticles/Nanoparticles of a Novel RhoA/Rho Kinase Inhibitor with Lung Surfactant Biomimetic Phospholipids for Targeted Lung Delivery. ACS Pharmacology & Translational Science 2024; 7(10): 3241 doi: 10.1021/acsptsci.4c00432
|
| 29 |
A. Zimmer, R. B. Teixeira, J. H. P. Bonetto, A. C. Bahr, P. Türck, A. L. de Castro, C. Campos-Carraro, F. Visioli, T. R. Fernandes-Piedras, K. R. Casali, C. M. C. Scassola, G. Baldo, A. S. Araujo, P. Singal, A. Belló-Klein. Role of inflammation, oxidative stress, and autonomic nervous system activation during the development of right and left cardiac remodeling in experimental pulmonary arterial hypertension. Molecular and Cellular Biochemistry 2020; 464(1-2): 93 doi: 10.1007/s11010-019-03652-2
|
| 30 |
Daniel Moreira-Gonçalves, Rita Ferreira-Nogueira, Mário Santos, Ana Filipa Silva, Rita Ferreira, Adelino Leite-Moreira, José Alberto Duarte, Tiago Henriques-Coelho. Exercise for Cardiovascular Disease Prevention and Treatment. Advances in Experimental Medicine and Biology 2017; 999: 307 doi: 10.1007/978-981-10-4307-9_17
|
| 31 |
Mita Das, Joshua Fessel, Haiyang Tang, James West. A Process‐Based Review of Mouse Models of Pulmonary Hypertension. Pulmonary Circulation 2012; 2(4): 415 doi: 10.4103/2045-8932.105030
|
| 32 |
Gerald J. Maarman. Pulmonary Vasculature Redox Signaling in Health and Disease. Advances in Experimental Medicine and Biology 2017; 967: 161 doi: 10.1007/978-3-319-63245-2_10
|
| 33 |
Xiaowu Wang, Yongchao Yang, Dongpeng Yang, Guang Tong, Shanshan Lv, Xi Lin, Changfu Chen, Wenpeng Dong. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1. Journal of Vascular Surgery 2016; 64(5): 1468 doi: 10.1016/j.jvs.2015.09.016
|
| 34 |
Benoît Ranchoux, Jolyane Meloche, Roxane Paulin, Olivier Boucherat, Steeve Provencher, Sébastien Bonnet. DNA Damage and Pulmonary Hypertension. International Journal of Molecular Sciences 2016; 17(6): 990 doi: 10.3390/ijms17060990
|
| 35 |
Agnieszka P. Grzegorzewska, Francesca Seta, Rong Han, Caitlin A. Czajka, Katsunari Makino, Lukasz Stawski, Jeffrey S. Isenberg, Jeffrey L. Browning, Maria Trojanowska. Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways. Scientific Reports 2017; 7(1) doi: 10.1038/srep41605
|
| 36 |
Mei Li Ng, Xu Ang, Kwan Yi Yap, Jun Jie Ng, Eugene Chen Howe Goh, Benjamin Bing Jie Khoo, Arthur Mark Richards, Chester Lee Drum. Novel Oxidative Stress Biomarkers with Risk Prognosis Values in Heart Failure. Biomedicines 2023; 11(3): 917 doi: 10.3390/biomedicines11030917
|
| 37 |
Sebastian Steven, Matthias Oelze, Moritz Brandt, Elisabeth Ullmann, Swenja Kröller-Schön, Tjebo Heeren, Lan P. Tran, Steffen Daub, Mobin Dib, Dirk Stalleicken, Philip Wenzel, Thomas Münzel, Andreas Daiber, Neven Zarkovic. Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin‐1 Signaling in Monocrotaline‐Induced Pulmonary Hypertension. Oxidative Medicine and Cellular Longevity 2017; 2017(1) doi: 10.1155/2017/4353462
|
| 38 |
Satoshi Ishii, Masaru Hatano, Hisataka Maki, Shun Minatsuki, Akihito Saito, Hiroki Yagi, Mai Shimbo, Katsura Soma, Genri Numata, Takayuki Fujiwara, Norifumi Takeda, Issei Komuro. Prognostic value of follow-up vasoreactivity test in pulmonary arterial hypertension. Journal of Cardiology 2023; 82(1): 69 doi: 10.1016/j.jjcc.2023.01.005
|
| 39 |
Matthew Mikhael, Christian Makar, Amir Wissa, Trixie Le, Mansoureh Eghbali, Soban Umar. Oxidative Stress and Its Implications in the Right Ventricular Remodeling Secondary to Pulmonary Hypertension. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.01233
|
| 40 |
Samantha Sharma, Micheala A. Aldred. DNA Damage and Repair in Pulmonary Arterial Hypertension. Genes 2020; 11(10): 1224 doi: 10.3390/genes11101224
|
| 41 |
Pei-Yi Chu, Yu-Cheng Wu, Ya-Ling Lin, Hung Chang, Shih-Chun Lee, Tsai-Wang Huang, Yuan-Ming Tsai. Surgical Treatment for Empyema Thoracis: Prognostic Role of Preoperative Transthoracic Echocardiography and Serum Calcium. Journal of Personalized Medicine 2022; 12(6): 1014 doi: 10.3390/jpm12061014
|
| 42 |
Guanghong Jia, Annayya R. Aroor, Luis A. Martinez-Lemus, James R. Sowers. Mitochondrial functional impairment in response to environmental toxins in the cardiorenal metabolic syndrome. Archives of Toxicology 2015; 89(2): 147 doi: 10.1007/s00204-014-1431-3
|
| 43 |
Haiying Chen, Padraig Strappe, Shuangfeng Chen, Le-Xin Wang. Endothelial Progenitor Cells and Pulmonary Arterial Hypertension. Heart, Lung and Circulation 2014; 23(7): 595 doi: 10.1016/j.hlc.2014.02.007
|
| 44 |
Ruslan Rafikov, Joel James, Nolan McClain, Stevan P. Tofovic, Olga Rafikova. Role of Gender in Regulation of Redox Homeostasis in Pulmonary Arterial Hypertension. Antioxidants 2019; 8(5): 135 doi: 10.3390/antiox8050135
|
| 45 |
Nannan Zhang, Bradley T Andresen, Cuihua Zhang. Inflammation and reactive oxygen species in cardiovascular disease. World Journal of Cardiology 2010; 2(12): 408-410 doi: 10.4330/wjc.v2.i12.408
|
| 46 |
Michael R. La Frano, Johannes F. Fahrmann, Dmitry Grapov, Theresa L. Pedersen, John W. Newman, Oliver Fiehn, Mark A. Underwood, Karen Mestan, Robin H. Steinhorn, Stephen Wedgwood. Umbilical cord blood metabolomics reveal distinct signatures of dyslipidemia prior to bronchopulmonary dysplasia and pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 2018; 315(5): L870 doi: 10.1152/ajplung.00283.2017
|
| 47 |
Jacqueline Pichler Hefti, Denise Sonntag, Urs Hefti, Lorenz Risch, Otto D. Schoch, Alexander J. Turk, Thomas Hess, Konrad E. Bloch, Marco Maggiorini, Tobias M. Merz, Klaus M. Weinberger, Andreas R. Huber. Oxidative Stress in Hypobaric Hypoxia and Influence on Vessel-Tone Modifying Mediators. High Altitude Medicine & Biology 2013; 14(3): 273 doi: 10.1089/ham.2012.1110
|
| 48 |
Kathryn S. Wilson, Hanna Buist, Kornelija Suveizdyte, John T. Liles, Grant R. Budas, Colin Hughes, Margaret R. MacLean, Martin Johnson, Alistair C. Church, Andrew J. Peacock, David J. Welsh. Apoptosis signal‐regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension. Pulmonary Circulation 2020; 10(2): 1 doi: 10.1177/2045894020922810
|
| 49 |
Himanshu Meghwani, Pankaj Prabhakar, Soheb A. Mohammed, Sandeep Seth, Milind P. Hote, Sanjay K. Banerjee, Sudheer Arava, Ruma Ray, Subir Kumar Maulik. Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension. Journal of Ethnopharmacology 2017; 197: 184 doi: 10.1016/j.jep.2016.07.029
|
| 50 |
Perinur Bozaykut, Betul Karademir, Burak Yazgan, Erdi Sozen, Richard C.M. Siow, Giovanni E. Mann, Nesrin Kartal Ozer. Effects of vitamin E on peroxisome proliferator-activated receptor γ and nuclear factor-erythroid 2-related factor 2 in hypercholesterolemia-induced atherosclerosis. Free Radical Biology and Medicine 2014; 70: 174 doi: 10.1016/j.freeradbiomed.2014.02.017
|
| 51 |
Tian-Tian Zhu, Wei-Fang Zhang, Ping Luo, Zhao-Xin Qian, Feng Li, Zheng Zhang, Chang-Ping Hu. LOX-1 promotes right ventricular hypertrophy in hypoxia-exposed rats. Life Sciences 2017; 174: 35 doi: 10.1016/j.lfs.2017.02.016
|
| 52 |
Mirjana Jerkic, Mohammed G. Kabir, Adrienne Davies, Lisa X. Yu, Brendan A.S. McIntyre, Nasir W. Husain, Masahiro Enomoto, Valentin Sotov, Mansoor Husain, Mark Henkelman, Jaques Belik, Michelle Letarte. Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress. Cardiovascular Research 2011; 92(3): 375 doi: 10.1093/cvr/cvr232
|
| 53 |
Giuseppe Caruso, Claudia G. Fresta, Margherita Grasso, Rosa Santangelo, Giuseppe Lazzarino, Susan M. Lunte, Filippo Caraci. Inflammation as the Common Biological Link Between Depression and Cardiovascular Diseases: Can Carnosine Exert a Protective Role?. Current Medicinal Chemistry 2020; 27(11): 1782 doi: 10.2174/0929867326666190712091515
|
| 54 |
Daria S. Kostyunina, Paul McLoughlin. Sex Dimorphism in Pulmonary Hypertension: The Role of the Sex Chromosomes. Antioxidants 2021; 10(5): 779 doi: 10.3390/antiox10050779
|
| 55 |
Gerald Maarman, Dee Blackhurst, Friedrich Thienemann, Lori Blauwet, Ghazwan Butrous, Neil Davies, Karen Sliwa, Sandrine Lecour. Melatonin as a preventive and curative therapy against pulmonary hypertension. Journal of Pineal Research 2015; 59(3): 343 doi: 10.1111/jpi.12263
|
| 56 |
Gerald J. Maarman. Reviewing the suitability of mitochondrial transplantation as therapeutic approach for pulmonary hypertension in the era of personalized medicine. American Journal of Physiology-Lung Cellular and Molecular Physiology 2022; 322(5): L641 doi: 10.1152/ajplung.00484.2021
|
| 57 |
Nilesh Gupta, Fahad I. Al-Saikhan, Brijeshkumar Patel, Jahidur Rashid, Fakhrul Ahsan. Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs. International Journal of Pharmaceutics 2015; 488(1-2): 33 doi: 10.1016/j.ijpharm.2015.04.031
|
| 58 |
Joel James, Marina Zemskova, Cody A. Eccles, Mathews V. Varghese, Maki Niihori, Natalie K. Barker, Moulun Luo, Lawrence J. Mandarino, Paul R. Langlais, Olga Rafikova, Ruslan Rafikov.
Single Mutation in the
NFU1
Gene Metabolically Reprograms Pulmonary Artery Smooth Muscle Cells
. Arteriosclerosis, Thrombosis, and Vascular Biology 2021; 41(2): 734 doi: 10.1161/ATVBAHA.120.314655
|
| 59 |
Véronique Freund-Michel, Christelle Guibert, Mathilde Dubois, Arnaud Courtois, Roger Marthan, Jean-Pierre Savineau, Bernard Muller. Reactive oxygen species as therapeutic targets in pulmonary hypertension. Therapeutic Advances in Respiratory Disease 2013; 7(3): 175 doi: 10.1177/1753465812472940
|
| 60 |
Guanghong Jia, Annayya R. Aroor, James R. Sowers. The Mitochondrion in Aging and Disease. Progress in Molecular Biology and Translational Science 2014; 127: 229 doi: 10.1016/B978-0-12-394625-6.00009-X
|
| 61 |
Basar Sirmagul, Sinem Ilgin, Ozlem Atli, Suzan Emel Usanmaz, Emine Demirel-Yilmaz. Assessment of the Endothelial Functions in Monocrotaline-induced Pulmonary Hypertension. Clinical and Experimental Hypertension 2013; 35(3): 220 doi: 10.3109/10641963.2012.721838
|
| 62 |
Gusty Rizky Teguh Ryanto, Ratoe Suraya, Tatsuya Nagano. Mitochondrial Dysfunction in Pulmonary Hypertension. Antioxidants 2023; 12(2): 372 doi: 10.3390/antiox12020372
|
| 63 |
Patrick Türck, Isadora Schein Salvador, Cristina Campos-Carraro, Vanessa Ortiz, Alan Bahr, Michael Andrades, Adriane Belló-Klein, Alex Sander da Rosa Araujo. Blueberry extract improves redox balance and functional parameters in the right ventricle from rats with pulmonary arterial hypertension. European Journal of Nutrition 2022; 61(1): 373 doi: 10.1007/s00394-021-02642-9
|
| 64 |
Julia Wiedemann, Robert P. Coppes, Peter van Luijk. Radiation-induced cardiac side-effects: The lung as target for interacting damage and intervention. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.931023
|
| 65 |
Min Zhang, Zhi Chang, Fang Zhao, Peng Zhang, Yin-Ju Hao, Lin Yan, Ning Liu, Jun-Li Wang, Lei Bo, Ping Ma, Wei Zhou, Xuan Ma, Qing-Bin Xu, Ru Zhou. Protective Effects of 18β-Glycyrrhetinic Acid on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00013
|
| 66 |
Jiantao Sun, Jiali Cheng, Xue Ding, Jing Chi, Jiemei Yang, Weimin Li. β3 adrenergic receptor antagonist SR59230A exerts beneficial effects on right ventricular performance in monocrotaline‑induced pulmonary arterial hypertension. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8236
|
| 67 |
Chao Xue, Mark Sowden, Bradford C. Berk. Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 2017; 37(6): 1138 doi: 10.1161/ATVBAHA.117.309212
|
| 68 |
Maria F. Acosta, Priya Muralidhran, Michael D. Abrahamson, Carissa L. Grijalva, Megan Carver, Haiyang Tang, Christina Klinger, Jeffrey R. Fineman, Stephen M. Black, Heidi M. Mansour. Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH. Pulmonary Pharmacology & Therapeutics 2020; 65: 101998 doi: 10.1016/j.pupt.2021.101998
|
| 69 |
Paul I. Tyan, Amr H. Radwan, Assaad Eid, Anthony G. Haddad, David Wehbe, Ali T. Taher. Novel Approach to Reactive Oxygen Species in Nontransfusion-Dependent Thalassemia. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/350432
|
| 70 |
Negin Delfani, Mohsen Daneshyar, Parviz Farhoomand, Younes Ali Alijoo, Sina Payvastegan, Gholamreza Najafi. Effects of arginine and guanidinoacetic acid with or without phenylalanine on ascites susceptibility in cold-stressed broilers fed canola meal-based diet. Journal of Animal Science and Technology 2023; 65(1): 69 doi: 10.5187/jast.2022.e68
|
| 71 |
Leah R. Villegas, Dylan Kluck, Carlie Field, Rebecca E. Oberley-Deegan, Crystal Woods, Michael E. Yeager, Karim C. El Kasmi, Rashmin C. Savani, Russell P. Bowler, Eva Nozik-Grayck. Superoxide Dismutase Mimetic, MnTE-2-PyP, Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension, Pulmonary Vascular Remodeling, and Activation of the NALP3 Inflammasome. Antioxidants & Redox Signaling 2013; 18(14): 1753 doi: 10.1089/ars.2012.4799
|
| 72 |
Stephanie Puukila, Rafael Oliveira Fernandes, Patrick Türck, Cristina Campos Carraro, Jéssica Hellen Poletto Bonetto, Bruna Gazzi de Lima-Seolin, Alex Sander da Rosa Araujo, Adriane Belló-Klein, Douglas Boreham, Neelam Khaper. Secoisolariciresinol diglucoside attenuates cardiac hypertrophy and oxidative stress in monocrotaline-induced right heart dysfunction. Molecular and Cellular Biochemistry 2017; 432(1-2): 33 doi: 10.1007/s11010-017-2995-z
|
| 73 |
Amit Kumar, Manisha Vaish, Saravanan S Karuppagounder, Irina Gazaryan, John W Cave, Anatoly A Starkov, Elizabeth T Anderson, Sheng Zhang, John T Pinto, Austin M Rountree, Wang Wang, Ian R Sweet, Rajiv R Ratan. HIF1α stabilization in hypoxia is not oxidant-initiated. eLife 2021; 10 doi: 10.7554/eLife.72873
|
| 74 |
Bin Liu, Xiu-Ju Luo, Zhong-Bao Yang, Jie-Jie Zhang, Ting-Bo Li, Xiao-Jie Zhang, Qi-Lin Ma, Guo-Gang Zhang, Chang-Ping Hu, Jun Peng. Inhibition of NOX/VPO1 Pathway and Inflammatory Reaction by Trimethoxystilbene in Prevention of Cardiovascular Remodeling in Hypoxia-induced Pulmonary Hypertensive Rats. Journal of Cardiovascular Pharmacology 2014; 63(6): 567 doi: 10.1097/FJC.0000000000000082
|
| 75 |
Maria Elena Manni, Stefania Rigacci, Elisabetta Borchi, Valentina Bargelli, Caterina Miceli, Carla Giordano, Laura Raimondi, Chiara Nediani, Mohammad T. Elnakish. Monoamine Oxidase Is Overactivated in Left and Right Ventricles from Ischemic Hearts: An Intriguing Therapeutic Target. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/4375418
|
| 76 |
Angela L Schenewerk, Francisco Í Ramírez, Christopher Foote, Tieming Ji, Luis A Martínez-Lemus, Rocío Melissa Rivera. Effects of the use of assisted reproduction and high-caloric diet consumption on body weight and cardiovascular health of juvenile mouse offspring. REPRODUCTION 2014; 147(1): 111 doi: 10.1530/REP-13-0354
|
| 77 |
Jia-Yin Fu, Ling-Bo Qian, Lie-Gang Zhu, Hao-Te Liang, Yi-Nuo Tan, Han-Ti Lu, Jian-Feng Lu, Hui-Ping Wang, Qiang Xia. Betulinic acid ameliorates endothelium-dependent relaxation in l-NAME-induced hypertensive rats by reducing oxidative stress. European Journal of Pharmaceutical Sciences 2011; 44(3): 385 doi: 10.1016/j.ejps.2011.08.025
|
| 78 |
Eva Nozik-Grayck, Crystal Woods, Joann M. Taylor, Richard K. P. Benninger, Richard D. Johnson, Leah R. Villegas, Kurt R. Stenmark, David G. Harrison, Susan M. Majka, David Irwin, Kathryn N. Farrow. Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 2014; 307(11): L868 doi: 10.1152/ajplung.00096.2014
|
| 79 |
Zuwen Zhang, Benjamin Trautz, Damir Kračun, Frederick Vogel, Michael Weitnauer, Katharina Hochkogler, Andreas Petry, Agnes Görlach. Stabilization of p22phox by Hypoxia Promotes Pulmonary Hypertension. Antioxidants & Redox Signaling 2019; 30(1): 56 doi: 10.1089/ars.2017.7482
|
| 80 |
Sayoko Ogura, Tatsuo Shimosawa, ShengYu Mu, Takashi Sonobe, Fumiko Kawakami-Mori, Hong Wang, Yuzaburo Uetake, Kenichi Yoshida, Yutaka Yatomi, Mikiyasu Shirai, Toshiro Fujita. Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor. American Journal of Physiology-Heart and Circulatory Physiology 2013; 305(2): H155 doi: 10.1152/ajpheart.00169.2012
|
| 81 |
Nilesh Gupta, Jahidur Rashid, Eva Nozik-Grayck, Ivan F. McMurtry, Kurt R. Stenmark, Fakhrul Ahsan. Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency. Molecular Pharmaceutics 2017; 14(3): 830 doi: 10.1021/acs.molpharmaceut.6b01061
|
| 82 |
Yuhan Qin, Yong Qiao, Dong Wang, Linqing Li, Mingkang Li, Gaoliang Yan, Chengchun Tang, Marco Malaguti. Target Nuclear Factor Erythroid 2-Related Factor 2 in Pulmonary Hypertension: Molecular Insight into Application. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/7845503
|
| 83 |
Grant R. Budas, Mario Boehm, Baktybek Kojonazarov, Gayathri Viswanathan, Xia Tian, Swathi Veeroju, Tatyana Novoyatleva, Friedrich Grimminger, Ford Hinojosa-Kirschenbaum, Hossein A. Ghofrani, Norbert Weissmann, Werner Seeger, John T. Liles, Ralph T. Schermuly. ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine 2018; 197(3): 373 doi: 10.1164/rccm.201703-0502OC
|
| 84 |
Bruna Gazzi de Lima-Seolin, Matheus Mittmann Hennemann, Rafael Oliveira Fernandes, Rafael Colombo, Jéssica Hellen Poletto Bonetto, Rayane Brinck Teixeira, Neelam Khaper, Alessandra Eifler Guerra Godoy, Isnard Elman Litvin, Alex Sander da Rosa Araujo, Paulo Cavalheiro Schenkel, Adriane Belló-Klein. Bucindolol attenuates the vascular remodeling of pulmonary arteries by modulating the expression of the endothelin-1 A receptor in rats with pulmonary arterial hypertension. Biomedicine & Pharmacotherapy 2018; 99: 704 doi: 10.1016/j.biopha.2018.01.127
|
| 85 |
Yonghong Xiang, Fei Zheng, Qinzhe Zhang, RunJuan Zhang, Haiyan Pan, Zongdong Pang, Shimin Dai, Yurong Zhang, Ye Wu, Lunkai Yao, Mengju Su, Luying Lan, Damião Pergentino De Sousa. Tanreqing Injection Regulates Cell Function of Hypoxia-Induced Human Pulmonary Artery Smooth Muscle Cells (HPASMCs) through TRPC1/CX3CL1 Signaling Pathway. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/3235102
|
| 86 |
Qian Li, Min Mao, Yanli Qiu, Gaofeng Liu, Tingting Sheng, Xiufeng Yu, Shuang Wang, Daling Zhu, Tim Lahm. Key Role of ROS in the Process of 15-Lipoxygenase/15-Hydroxyeicosatetraenoiccid-Induced Pulmonary Vascular Remodeling in Hypoxia Pulmonary Hypertension. PLOS ONE 2016; 11(2): e0149164 doi: 10.1371/journal.pone.0149164
|
| 87 |
Feng Chen, Xueyi Li, Emily Aquadro, Stephen Haigh, Jiliang Zhou, David W. Stepp, Neal L. Weintraub, Scott A. Barman, David J.R. Fulton. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension. Free Radical Biology and Medicine 2016; 99: 167 doi: 10.1016/j.freeradbiomed.2016.08.003
|
| 88 |
Ivan Bernardo, Steven Bozinovski, Ross Vlahos. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities. Pharmacology & Therapeutics 2015; 155: 60 doi: 10.1016/j.pharmthera.2015.08.005
|
| 89 |
Ana Filipa Silva, Fábio Sousa‐Nunes, Gabriel Faria‐Costa, Ilda Rodrigues, João Tiago Guimarães, Adelino Leite‐Moreira, Tiago Henriques‐Coelho, Rita Negrão, Daniel Moreira‐Gonçalves. Effects of chronic moderate alcohol consumption on right ventricle and pulmonary remodelling. Experimental Physiology 2021; 106(6): 1359 doi: 10.1113/EP088788
|